Readily raises $11 million for insurer compliance. Endpoints News reported that Readily has raised $11 million to help health insurers stay compliant. The raise is small, but the buyer problem is not: payer compliance work has expanded with every new state AI and prior authorization rule, including the state laws now taking effect in 2026.
Apogee executives join Paragon. Endpoints News reported that executives from Apogee Therapeutics are joining Paragon to scale its research and company creation engine. The move pairs naturally with today’s Velaris story: Apogee was Paragon’s one IPO route spinout before its sale to AbbVie, and its alumni now staff the machine that produced it.
MHRA safety alert on renal replacement filters. The MHRA issued a drug safety alert (DSI/2026/014) advising clinicians to consider delaying echinocandin antifungals such as caspofungin when a patient starts continuous renal replacement therapy on new polyacrylonitrile based filter membranes, because the drug can adsorb onto the membrane and lose effect. It is a narrow, practical alert aimed at intensive care teams rather than a product withdrawal.
Helen Branswell dies at 69. STAT announced the death of its senior infectious diseases reporter, whose coverage of Ebola, influenza and Covid 19 set the standard for outbreak reporting and shaped how regulators and the public understood emerging pathogens. The beat notes it because her sourcing inside public health agencies was, for a decade, part of the information infrastructure this sector trades on.